How many employees work at Knight Therapeutics?
Knight Therapeutics, Inc. has 525 employees, according to Revelio Labs workforce intelligence data. The YoY growth rate is 15.2%.
Data source: Revelio Labs Coverage: Global workforce Latest update: December 2025
About Knight Therapeutics
Knight Therapeutics Inc. is a pan-American (ex-US) specialty pharmaceutical company focused on acquiring, in licensing, out-licensing, marketing, and commercializing innovative prescription pharmaceuticals in Canada and Latin America. Knight owns Biotoscana Investments S.A., a pan-Latin American specialty pharmaceutical company. Knight Therapeutics Inc.’s shares trade on TSX under the symbol GUD. Headquartered in Montreal, Knight has over 700 employees globally.
As of December 2025
Knight Therapeutics
workforce metrics
Headcount
525
Avg. Salary
$43.9k
Tenure
2.5yr
Growth Rate
15.2%
Hiring Rate
Attrition Rate
For even more metrics data,
reach out to our sales team.
Employee Headcount
Interactive chart of Knight Therapeutics annual worldwide employee count from 2023 to 2025.
- Knight Therapeutics total number of employees in 2025 was 525, a 15.2% increase from 2024.
- Knight Therapeutics total number of employees in 2024 was 450, a 6.7% increase from 2023.
- Knight Therapeutics total number of employees in 2023 was 421, a 4.3% increase from 2022.
Would you like to see the latest employee headcount data?
Employee Geographic Breakdown
Would you like to see the latest employee geographic data?
Active Job Postings
Interactive chart of Knight Therapeutics annual active job postings from 2023 to 2025.
- Knight Therapeutics active job postings in 2025 was 9, a 0% no change from 2024.
- Knight Therapeutics active job postings in 2024 was 9, a 200.0% increase from 2023.
- Knight Therapeutics active job postings in 2023 was 0, a 200.0% decline from 2022.
Would you like to see the latest active job postings data?
Employee Sentiment
Sentiment Topics
Would you like to see the latest employee sentiment data?